Drawing for BOSTAL

USPTO serial 88114633

BOSTAL

Reviewed by CopyMark Law Group

Reg. 6413916Status 700Renewal
Filing date
Status date
Registration date
Jul 13, 2021
Examiner
EVANKO, PATRICIA MALESARDI
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with BOSTAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $325

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevin S. Costanza

Kevin S. Costanza SEED IP LAW GROUP LLP701 FIFTH AVENUESUITE 5400SEATTLE, WA 98104

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical drugs for treatment of infectious diseases; Chewing gum for medical purposes; ß-blockers; Drugs for medical purposes, namely, valsartan; Antioxidant drugs, namely, antioxidant food supplements; Pre-filled syringes for medical purposes filled with pharmaceutical preparations, namely, pharmaceutical preparations for treating nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Nutraceutical preparations for therapeutic or medical purposes, namely, nutraceuticals for the treatment of nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Chemical preparations for medical purposes for the treatment of illnesses or conditions, namely, nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseases; Pharmaceutical preparations for the treatment of illnesses or conditions, namely, nausea, cancer, hypertension, heart disease, hepatitis, rheumatoid arthritis, inflammation, insomnia, nephropathy, hepatopathy, Parkinson's disease, insomnia, overactive bladder, oculopathy, encephalopathy, otopathy, stomatopathy, rhinopathy, splenopathy, pulmonary disease, dermopathy, encephalopathy, osteopathy, hemopathy, endocrinopathy, diabetes, immunological diseases, respiratory diseasesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 13, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 13, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 9, 2021DP1B1(B) BASIS DELETED; PROCEED TO REGISTRATION—
Jun 9, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 20, 2021IUCNNOTICE OF ALLOWANCE CANCELLED—
May 20, 2021D1BRTEAS DELETE 1(B) BASIS RECEIVED—
Mar 2, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 5, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 5, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Nov 30, 2020FIXDELECTRONIC RECORD REVIEW COMPLETE—
Nov 27, 2020ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Nov 20, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 19, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 18, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 18, 2020ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
May 19, 2020GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
May 19, 2020GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 19, 2020CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 13, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 13, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 12, 2020ALIEASSIGNED TO LIE—
May 8, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 28, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Mar 28, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 28, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 28, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 28, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 21, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jan 21, 2020GNSIINQUIRY TO SUSPENSION E-MAILED—
Jan 21, 2020CNSISUSPENSION INQUIRY WRITTEN—
Jan 6, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Jul 1, 2019GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Jul 1, 2019GNSLLETTER OF SUSPENSION E-MAILED—
Jul 1, 2019CNSLSUSPENSION LETTER WRITTEN—
Jun 21, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 20, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 20, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 21, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Dec 21, 2018DOCKASSIGNED TO EXAMINER—
Oct 1, 2018AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Sep 30, 2018ALIEASSIGNED TO LIE—
Sep 20, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 19, 2018PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Sep 15, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance